Driving Biopharma Efficiencies With MES

By Emiliee Cook

The pharmaceutical industry’s landscape is changing. As the industry shifts toward more complex manufacturing processes with biologics and cell & gene therapies, there’s greater pressure to increase operational speed, reliability, quality, and safety. Yet traditional manufacturing execution systems fail to meet the industry’s changing needs and challenges.

In an effort to address this important issue, I recently collaborated with fellow industry leaders to create an MES of the Future manifesto for the BioPhorum group. BioPhorum leads more than 90 industry-changing initiatives and brings together thousands of subject matter experts to collaborate on challenges in existing and emerging topics that affect the whole industry.

This manifesto highlights the gap between the current generation of MES solutions and addresses the challenges facing the biomanufacturing industry. As a call to action for the biopharma industry, it is intended to stimulate collaboration between biomanufacturers and vendors of MES solutions and inspire change.

Continue reading to learn more about how the manifesto articulates the gap between the current generation of MES solutions and the needs of industry and outlines a realistic and achievable vision for the MES of the future that will meet the needs of biomanufacturing plants.